TEAR 2.26 Tearlab Corp $TEAR Hit a 52 week low of 2.05 Closing the day 11/06/14 at 2.26 -0.41 -15.36% With a day low of 2.05 and a total volume of 1,183,086.
TEAR Recent Posts: http://investorshangout.com/TearLab-Corp-TEAR-55615/
TEAR Tearlab Corp Recent Headline News
TearLab Corporation Reports Q3-14 Financial Results
GlobeNewswire - Wed Nov 05, 3:37PM CST
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
today reported its consolidated financial results for the third quarter ended September 30, 2014. All dollar amounts are expressed in U.S. currency and results are reported in accordance with United States generally accepted accounting principles.
TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
TearLab Corporation to Release Q3 2014 Financial Results on November 5, 2014
GlobeNewswire - Wed Oct 22, 3:00PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" expects to announce its Q3 2014 financial results after market closes on Wednesday November 5, 2014. TearLab is pleased to invite all willing participants in a conference call during which time financial results will be discussed. This call will be held at 4:30pm Eastern at 877-303-1593.
TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
Julie Speed Joins TearLab as Vice President, Global Marketing
GlobeNewswire - Mon Oct 06, 3:15PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" today announced the appointment of Julie Speed to its senior management team as Vice President, Global Marketing.
TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
TearLab to Participate in BTIG's Inaugural Emerging Technologies in Healthcare Diagnostics Symposium
GlobeNewswire - Thu Sep 25, 3:15PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" announced today that its Chief Executive Officer, Elias Vamvakas, will participate in the BTIG Emerging Technologies in Healthcare Diagnostics Symposium on Tuesday, September 30, 2014 at the Benjamin Hotel in New York City.
TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
Study Demonstrates Hyperosmolarity of the Ocular Surface May Impact Cataract Surgery Planning
GlobeNewswire - Mon Sep 15, 3:39PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" announced that preliminary results of the TearLab Cataract Study were presented today at the XXXIII Congress of the European Society of Cataract and Refractive Surgeons ("ESCRS" .
TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
TearLab to Participate in Craig-Hallum's 5th Annual Alpha Select Conference
GlobeNewswire - Thu Sep 11, 7:30AM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" announced today that its Chief Executive Officer, Elias Vamvakas, will present an update on the Company's business at the 5th Annual Craig-Hallum Alpha Select Conference on Thursday, September 18, 2014 at 2:50 p.m. Eastern Time at the Convene Conference Center in New York City.
TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
TearLab Reports Interim Results From Multi-Center DED Prevalence Study in the UK
GlobeNewswire - Thu Sep 04, 7:36AM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" today announced interim results of a multi-center dry eye disease ("DED" prevalence study being carried out in the United Kingdom at four National Health Service ("NHS" hospitals.
TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
TearLab to Host Analyst and Investor Day
GlobeNewswire - Thu Aug 14, 10:59AM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" announced today that it will host an "Analyst and Investor Day" in San Diego, CA on Tuesday, September 23, 2014. The event will be held at the Company's offices at 9980 Huennekens St. from 10:00am to 4:00pm Pacific Time.
TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
TearLab to Participate in the Canaccord Genuity 34th Annual Growth Conference
GlobeNewswire - Mon Aug 11, 7:30AM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" announced today that its President & COO, Seph Jensen, will present an update on the Company's business at the Canaccord Genuity 34th Annual Growth Conference on Thursday, August 14, 2014 at 3:30 p.m. Eastern Time. The conference will be held at the InterContinental Boston Hotel in Boston, MA.
TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
TearLab Corporation Reports Q2-14 Financial Results and Adjusts 2014 Revenue Guidance
GlobeNewswire - Thu Aug 07, 3:43PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" today reported its consolidated financial results for the second quarter ended June 30, 2014. All dollar amounts are expressed in U.S. currency and results are reported in accordance with United States generally accepted accounting principles.
TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
WEALTHMAKERS.COM Issues Bearish Research Reports on SLAB, TAP, TEAR, UAN, VICL, VSAT
M2 - Wed Jul 30, 9:44AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Silicon Laboratories Inc (NASDAQ:SLAB), Molson Coors Brewing Co (NYSE:TAP), Tearlab Corp (NASDAQ:TEAR), CVR Partners LP (NYSE:UAN), Vical Inc (NASDAQ:VICL), VIASAT, INC. (NASDAQ:VSAT)
VICL: 1.15 (-0.01), TEAR: 2.26 (-0.41), SLAB: 46.14 (-0.31), TAP: 77.05 (+2.89), UAN: 11.60 (-0.37), VSAT: 60.26 (-0.18)
TearLab Corporation to Release Q2 2014 Financial Results on August 7, 2014
GlobeNewswire - Wed Jul 16, 4:30PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) expects to announce its Q2 2014 financial results after market closes on Thursday, August 7, 2014. TearLab is pleased to invite all willing participants in a conference call during which time financial results will be discussed. That call will be held at 4:30pm Eastern at 877-303-1593.
TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
Manoj Venkiteshwar Joins TearLab as VP of Medical Affairs
GlobeNewswire - Mon Jul 14, 3:15PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" today announced the appointment of Manoj S. Venkiteshwar, PhD. to its senior management team in the newly created position of Vice President of Medical Affairs.
TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
Nasdaq stocks posting largest percentage increases
AP - Thu Jul 03, 12:17PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
VITC: 7.99 (unch), KVHI: 12.75 (-0.03), ISLE: 7.22 (-0.01), TEAR: 2.26 (-0.41), BSET: 18.25 (+0.15), AFOP: 13.72 (+0.42), ADHD: 3.87 (+0.23), SFLY: 40.92 (+0.47), TGTX: 11.18 (+0.49), HNRG: 11.89 (+0.10), JAXB: 10.61 (+0.11), GBIM: 6.91 (-0.44), ADEP: 8.18 (-0.09), PCMI: 10.60 (+0.50), BBSI: 22.87 (-0.18), POZN: 9.50 (+0.69), PETM: 71.64 (+1.24)
Financial Guidance, Appointments, Board Elections, and Technical Updates - Analyst Notes on Amedisys, Dyax, TearLab, Celladon and Alphatec
PR Newswire - Wed Jul 02, 5:00AM CDT
Today, Analysts Review released its analysts' notes regarding Amedisys Inc. (NASDAQ: AMED), Dyax Corp. (NASDAQ: DYAX), TearLab Corp. (NASDAQ: TEAR), Celladon Corp. (NASDAQ: CLDN) and Alphatec Holdings Inc. (NASDAQ: ATEC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4350-100free.
ATEC: 1.45 (+0.04), TEAR: 2.26 (-0.41), CLDN: 11.60 (+0.03), AMED: 25.17 (-0.37), DYAX: 13.05 (+0.70)
TearLab Announces Election of Directors
GlobeNewswire - Fri Jun 13, 3:02PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" announced that all of the nominees listed in the management information circular for the annual meeting of shareholders held on Wednesday, June 11, 2014 were elected as directors of the Company.
TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
TearLab Closes Acquisition of AOA's OcuHub Technology Platform
GlobeNewswire - Fri Mar 14, 11:30AM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" today announced the closing of the acquisition of the assets of the OcuHub business unit from AOAExcel, Inc., the for-profit subsidiary of the American Optometric Association ("AOA" .
TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
TearLab Corporation Reports 2013 Financial Results
GlobeNewswire - Thu Mar 13, 3:02PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" today reported its consolidated financial results for the quarter and the year ended December 31, 2013. All dollar amounts are expressed in U.S. currency and results are reported in accordance with United States generally accepted accounting principles.
TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
5 Hated Earnings Stocks You Should Love
at The Street - Tue Mar 11, 11:27AM CDT
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
DMND: 30.01 (-0.57), TEAR: 2.26 (-0.41), GOGO: 16.31 (-0.02), ADUS: 20.40 (+0.54), DXM: 9.35 (+0.33)
TearLab to Participate in March Investor Conferences
GlobeNewswire - Tue Mar 04, 8:00AM CST
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" announced today that the Company will participate in three investor conferences in March.
TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
TEAR Recent Posts: http://investorshangout.com/TearLab-Corp-TEAR-55615/
TEAR Tearlab Corp Recent Headline News
TearLab Corporation Reports Q3-14 Financial Results
GlobeNewswire - Wed Nov 05, 3:37PM CST
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
today reported its consolidated financial results for the third quarter ended September 30, 2014. All dollar amounts are expressed in U.S. currency and results are reported in accordance with United States generally accepted accounting principles. TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
TearLab Corporation to Release Q3 2014 Financial Results on November 5, 2014
GlobeNewswire - Wed Oct 22, 3:00PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
expects to announce its Q3 2014 financial results after market closes on Wednesday November 5, 2014. TearLab is pleased to invite all willing participants in a conference call during which time financial results will be discussed. This call will be held at 4:30pm Eastern at 877-303-1593. TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
Julie Speed Joins TearLab as Vice President, Global Marketing
GlobeNewswire - Mon Oct 06, 3:15PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
today announced the appointment of Julie Speed to its senior management team as Vice President, Global Marketing. TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
TearLab to Participate in BTIG's Inaugural Emerging Technologies in Healthcare Diagnostics Symposium
GlobeNewswire - Thu Sep 25, 3:15PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
announced today that its Chief Executive Officer, Elias Vamvakas, will participate in the BTIG Emerging Technologies in Healthcare Diagnostics Symposium on Tuesday, September 30, 2014 at the Benjamin Hotel in New York City. TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
Study Demonstrates Hyperosmolarity of the Ocular Surface May Impact Cataract Surgery Planning
GlobeNewswire - Mon Sep 15, 3:39PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
announced that preliminary results of the TearLab Cataract Study were presented today at the XXXIII Congress of the European Society of Cataract and Refractive Surgeons ("ESCRS" . TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
TearLab to Participate in Craig-Hallum's 5th Annual Alpha Select Conference
GlobeNewswire - Thu Sep 11, 7:30AM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
announced today that its Chief Executive Officer, Elias Vamvakas, will present an update on the Company's business at the 5th Annual Craig-Hallum Alpha Select Conference on Thursday, September 18, 2014 at 2:50 p.m. Eastern Time at the Convene Conference Center in New York City. TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
TearLab Reports Interim Results From Multi-Center DED Prevalence Study in the UK
GlobeNewswire - Thu Sep 04, 7:36AM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
today announced interim results of a multi-center dry eye disease ("DED" prevalence study being carried out in the United Kingdom at four National Health Service ("NHS" hospitals. TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
TearLab to Host Analyst and Investor Day
GlobeNewswire - Thu Aug 14, 10:59AM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
announced today that it will host an "Analyst and Investor Day" in San Diego, CA on Tuesday, September 23, 2014. The event will be held at the Company's offices at 9980 Huennekens St. from 10:00am to 4:00pm Pacific Time. TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
TearLab to Participate in the Canaccord Genuity 34th Annual Growth Conference
GlobeNewswire - Mon Aug 11, 7:30AM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
announced today that its President & COO, Seph Jensen, will present an update on the Company's business at the Canaccord Genuity 34th Annual Growth Conference on Thursday, August 14, 2014 at 3:30 p.m. Eastern Time. The conference will be held at the InterContinental Boston Hotel in Boston, MA. TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
TearLab Corporation Reports Q2-14 Financial Results and Adjusts 2014 Revenue Guidance
GlobeNewswire - Thu Aug 07, 3:43PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
today reported its consolidated financial results for the second quarter ended June 30, 2014. All dollar amounts are expressed in U.S. currency and results are reported in accordance with United States generally accepted accounting principles. TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
WEALTHMAKERS.COM Issues Bearish Research Reports on SLAB, TAP, TEAR, UAN, VICL, VSAT
M2 - Wed Jul 30, 9:44AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Silicon Laboratories Inc (NASDAQ:SLAB), Molson Coors Brewing Co (NYSE:TAP), Tearlab Corp (NASDAQ:TEAR), CVR Partners LP (NYSE:UAN), Vical Inc (NASDAQ:VICL), VIASAT, INC. (NASDAQ:VSAT)
VICL: 1.15 (-0.01), TEAR: 2.26 (-0.41), SLAB: 46.14 (-0.31), TAP: 77.05 (+2.89), UAN: 11.60 (-0.37), VSAT: 60.26 (-0.18)
TearLab Corporation to Release Q2 2014 Financial Results on August 7, 2014
GlobeNewswire - Wed Jul 16, 4:30PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) expects to announce its Q2 2014 financial results after market closes on Thursday, August 7, 2014. TearLab is pleased to invite all willing participants in a conference call during which time financial results will be discussed. That call will be held at 4:30pm Eastern at 877-303-1593.
TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
Manoj Venkiteshwar Joins TearLab as VP of Medical Affairs
GlobeNewswire - Mon Jul 14, 3:15PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
today announced the appointment of Manoj S. Venkiteshwar, PhD. to its senior management team in the newly created position of Vice President of Medical Affairs. TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
Nasdaq stocks posting largest percentage increases
AP - Thu Jul 03, 12:17PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
VITC: 7.99 (unch), KVHI: 12.75 (-0.03), ISLE: 7.22 (-0.01), TEAR: 2.26 (-0.41), BSET: 18.25 (+0.15), AFOP: 13.72 (+0.42), ADHD: 3.87 (+0.23), SFLY: 40.92 (+0.47), TGTX: 11.18 (+0.49), HNRG: 11.89 (+0.10), JAXB: 10.61 (+0.11), GBIM: 6.91 (-0.44), ADEP: 8.18 (-0.09), PCMI: 10.60 (+0.50), BBSI: 22.87 (-0.18), POZN: 9.50 (+0.69), PETM: 71.64 (+1.24)
Financial Guidance, Appointments, Board Elections, and Technical Updates - Analyst Notes on Amedisys, Dyax, TearLab, Celladon and Alphatec
PR Newswire - Wed Jul 02, 5:00AM CDT
Today, Analysts Review released its analysts' notes regarding Amedisys Inc. (NASDAQ: AMED), Dyax Corp. (NASDAQ: DYAX), TearLab Corp. (NASDAQ: TEAR), Celladon Corp. (NASDAQ: CLDN) and Alphatec Holdings Inc. (NASDAQ: ATEC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4350-100free.
ATEC: 1.45 (+0.04), TEAR: 2.26 (-0.41), CLDN: 11.60 (+0.03), AMED: 25.17 (-0.37), DYAX: 13.05 (+0.70)
TearLab Announces Election of Directors
GlobeNewswire - Fri Jun 13, 3:02PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
announced that all of the nominees listed in the management information circular for the annual meeting of shareholders held on Wednesday, June 11, 2014 were elected as directors of the Company. TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
TearLab Closes Acquisition of AOA's OcuHub Technology Platform
GlobeNewswire - Fri Mar 14, 11:30AM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
today announced the closing of the acquisition of the assets of the OcuHub business unit from AOAExcel, Inc., the for-profit subsidiary of the American Optometric Association ("AOA" . TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
TearLab Corporation Reports 2013 Financial Results
GlobeNewswire - Thu Mar 13, 3:02PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
today reported its consolidated financial results for the quarter and the year ended December 31, 2013. All dollar amounts are expressed in U.S. currency and results are reported in accordance with United States generally accepted accounting principles. TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
5 Hated Earnings Stocks You Should Love
at The Street - Tue Mar 11, 11:27AM CDT
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
DMND: 30.01 (-0.57), TEAR: 2.26 (-0.41), GOGO: 16.31 (-0.02), ADUS: 20.40 (+0.54), DXM: 9.35 (+0.33)
TearLab to Participate in March Investor Conferences
GlobeNewswire - Tue Mar 04, 8:00AM CST
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
announced today that the Company will participate in three investor conferences in March. TEAR: 2.26 (-0.41), TLB.TO: 2.50 (-0.72)
